CROI 2020 - CROI 2020

THEMED DISCUSSION: SHARPENING THE CUTTING EDGE: ADDITIONS TO THE MOLECULAR VIROLOGY TOOLKIT

"SESSION INTRODUCTION" by Alan N. Engelman of Dana-Farber Cancer Institute, Boston, MA, USA

THEMED DISCUSSION: SHARPENING THE CUTTING EDGE: ADDITIONS TO THE MOLECULAR VIROLOGY TOOLKIT

"HIV-1 CAPSID-NUCLEAR ENVELOPE INTERACTIONS THAT FACILITATE NUCLEAR IMPORT" by Mohamed Husen Munshi of National Cancer Institute, Frederick, MD, USA

THEMED DISCUSSION: SHARPENING THE CUTTING EDGE: ADDITIONS TO THE MOLECULAR VIROLOGY TOOLKIT

"REPORTER VIRUSES WITH PROTEIN BARCODES TO ANALYZE HIV LATENCY ESTABLISHMENT" by Eun Hye Grace Kim of Icahn School of Medicine at Mt Sinai, New York, NY, USA

THEMED DISCUSSION: SHARPENING THE CUTTING EDGE: ADDITIONS TO THE MOLECULAR VIROLOGY TOOLKIT

"GAG DETERMINANTS OF SPECIFIC GENOME PACKAGING IN HIV-1 AND HIV-2" by Jonathan Rawson of National Cancer Institute, Frederick, MD, USA

THEMED DISCUSSION: SHARPENING THE CUTTING EDGE: ADDITIONS TO THE MOLECULAR VIROLOGY TOOLKIT

"EXPLORING THE REQUIREMENTS FOR HIV-1 GENOME PACKAGING THROUGH A NONVIRAL RNA BINDING" by Alice Duchon of National Cancer Institute, FREDERICK, MD, USA

THEMED DISCUSSION: HEARTS AND HORMONES

"SESSION INTRODUCTION" by Markella V Zanni of Massachusetts General Hospital, Boston, MA, USA

THEMED DISCUSSION: HEARTS AND HORMONES

"TESTOSTERONE THERAPY AND SUBCLINICAL ATHEROSCLEROSIS PROGRESSION AMONG MEN WITH HIV" by Sabina A. Haberlen of Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA

THEMED DISCUSSION: HEARTS AND HORMONES

"POSTDISCHARGE OUTCOMES FOLLOWING ACUTE CORONARY SYNDROME IN HIV" by Monica Parks of University of California San Francisco, San Francisco, CA, USA

THEMED DISCUSSION: HEARTS AND HORMONES

"INSOMNIA AND RISK OF INCIDENT MYOCARDIAL INFARCTION AMONG PEOPLE LIVING WITH HIV" by Bridget M Whitney of University of Washington, Seattle, WA, USA

THEMED DISCUSSION: HEARTS AND HORMONES

"HORMONE USE AND HIV ALTER CARDIOVASCULAR BIOMARKER PROFILES IN TRANSGENDER WOMEN" by Jordan E Lake of University of Texas Health Science Center Houston, Houston, TX, USA

THEMED DISCUSSION: HEARTS AND HORMONES

"HIV SEVERITY AND INCIDENT HEART FAILURE AMONG PATIENTS IN A LARGE HEALTH CARE SYSTEM" by Jennifer O. Lam of Kaiser Permanente, Oakland, CA, USA

THEMED DISCUSSION: CHRONIC DISEASES IN MATERNAL HEALTH: PERSISTENT PROBLEMS FOR PREGNANT OR POSTPARTUM WOMEN

"SESSION INTRODUCTION" by Risa M. Hoffman of David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, CA, USA

THEMED DISCUSSION: CHRONIC DISEASES IN MATERNAL HEALTH: PERSISTENT PROBLEMS FOR PREGNANT OR POSTPARTUM WOMEN

"CHANGES IN BONE MINERAL DURING AND AFTER LACTATION IN UGANDAN WOMEN ON OPTION B+ ART" by Mary Glenn Fowler of Johns Hopkins University, Baltimore, MD, USA

THEMED DISCUSSION: CHRONIC DISEASES IN MATERNAL HEALTH: PERSISTENT PROBLEMS FOR PREGNANT OR POSTPARTUM WOMEN

"POSTPARTUM WEIGHT CHANGES IN WOMEN INITIATING DTG VS EFV IN PREGNANCY: DOLPHIN-2" by Thokozile Rosemary Malaba of University of Cape Town, Cape Town, South Africa

THEMED DISCUSSION: CHRONIC DISEASES IN MATERNAL HEALTH: PERSISTENT PROBLEMS FOR PREGNANT OR POSTPARTUM WOMEN

"DOLUTEGRAVIR USE IS ASSOCIATED WITH HIGHER POSTPARTUM WEIGHT COMPARED TO EFAVIRENZ" by Jennifer Jao of Northwestern University Feinberg School of Medicine, Chicago, IL, USA

THEMED DISCUSSION: CHRONIC DISEASES IN MATERNAL HEALTH: PERSISTENT PROBLEMS FOR PREGNANT OR POSTPARTUM WOMEN

"FACTORS ASSOCIATED WITH GESTATIONAL DIABETES IN HIV+ AND HIV– WOMEN IN PUNE, INDIA" by Puja Chebrolu of Weill Cornell Medicine, Columbus, GA, USA

THEMED DISCUSSION: CHRONIC DISEASES IN MATERNAL HEALTH: PERSISTENT PROBLEMS FOR PREGNANT OR POSTPARTUM WOMEN

"HIGH BLOOD PRESSURE AND ADVERSE BIRTH OUTCOMES IN HIV+ AND HIV– SOUTH AFRICAN WOMEN" by Angela Bengtson of Brown University, Providence, RI, USA

THEMED DISCUSSION: RAPID ART START: WHERE ARE THE GAPS?

"ASSOCIATION BETWEEN TIME TO ART AND LOSS TO CARE AMONG NEWLY DIAGNOSED PLWH IN RWANDA" by Jonathan Ross of Montefiore Medical Center / Albert Einstein College of Medicine, Bronx, NY, USA

THEMED DISCUSSION: RAPID ART START: WHERE ARE THE GAPS?

"SAME-DAY ART IN THAILAND: THE IMPACT OF ART INITIATION PERIODS ON TREATMENT OUTCOMES" by Pich Seekaew of Columbia University, New York, NY, USA

THEMED DISCUSSION: RAPID ART START: WHERE ARE THE GAPS?

"RAPID START LEADS TO SUSTAINED VIRAL SUPPRESSION IN YOUNG PEOPLE IN THE SOUTH" by Jason Halperin of CrescentCare, New Orleans, LA, USA

THEMED DISCUSSION: RAPID ART START: WHERE ARE THE GAPS?

"ASSESSMENT OF IMMEDIATE INITIATION OF ANTIRETROVIAL THERAPY IN NEW YORK CITY" by Daniel Bertolino of New York City Department of Health and Mental Hygiene, Queens, NY, USA

THEMED DISCUSSION: PARTNER NOTIFICATION FOR DETECTING HIV INFECTIONS

"SESSION INTRODUCTION" by Rachel Baggaley of World Health Organization, Geneva, Switzerland

THEMED DISCUSSION: PARTNER NOTIFICATION FOR DETECTING HIV INFECTIONS

"ASSISTED PARTNER NOTIFICATION SERVICES IN KAMPALA, UGANDA" by Florence Namimbi of Infectious Diseases Institute, Kampala, Uganda

THEMED DISCUSSION: PARTNER NOTIFICATION FOR DETECTING HIV INFECTIONS

"TARGETED PEER MOBILISATION AND ASSISTED PARTNER NOTIFICATION SERVICES IN KENYA" by Maartje Dijkstra of Public Health Service Amsterdam, Amsterdam, NE, Netherlands

THEMED DISCUSSION: PARTNER NOTIFICATION FOR DETECTING HIV INFECTIONS

"SCALE-UP OF ASSISTED PARTNER SERVICES (APS) IN BOTSWANA" by Matthew R Golden of University of Washington, Seattle, WA, USA

THEMED DISCUSSION: PARTNER NOTIFICATION FOR DETECTING HIV INFECTIONS

"OPTIMIZING TESTING INCREASES YIELD IN HIV CASE FINDING IN 24 COUNTRIES, 2018–2019" by Shahul Hameed Ebrahim of Centers for Disease Control, atlanta, GA, USA

THEMED DISCUSSION: PARTNER NOTIFICATION FOR DETECTING HIV INFECTIONS

"COMPARISON OF INDEX TESTING APPROACHES TO IMPROVE HIV-TESTING EFFICIENCY IN RWANDA" by Eric Remera of RWANDA BIOMEDICAL CENTRE, kigali, Rwanda

THEMED DISCUSSION: CURATIVE STRATEGIES: TRIALS AND TRIBULATIONS

"SESSION INTRODUCTION" by Pablo Tebas of University of Pennsylvania, Philadelphia, PA, USA

THEMED DISCUSSION: CURATIVE STRATEGIES: TRIALS AND TRIBULATIONS

"EFFECT OF TAMOXIFEN ON VORINOSTAT-INDUCED HIV RNA EXPRESSION IN WOMEN ON ART (A5366)" by Eileen P Scully of Johns Hopkins University, Baltimore, MD, USA

THEMED DISCUSSION: CURATIVE STRATEGIES: TRIALS AND TRIBULATIONS

"EFFECTS OF IMMUNE CHECKPOINT THERAPY ON LATENT HIV IN PEOPLE WITH HIV AND MALIGNANCY" by Jillian SY Lau of Alfred Hospital, Glen Iris, VIC, Australia

THEMED DISCUSSION: CURATIVE STRATEGIES: TRIALS AND TRIBULATIONS

"ABX464 DECREASES THE TOTAL HIV RESERVOIR AND HIV TRANSCRIPTION INITIATION IN VIVO" by Sara Moron-Lopez of University of California San Francisco - SFVAMC - NCIRE, San Francisco, CA, USA

THEMED DISCUSSION: CURATIVE STRATEGIES: TRIALS AND TRIBULATIONS

"ATTACKING LATENT HIV WITH CONVERTIBLE CAR-T CELLS, A MODULAR KILLING PLATFORM" by Eytan Herzig of University of California San Francisco, San Francisco, CA, USA

THEMED DISCUSSION: CURATIVE STRATEGIES: TRIALS AND TRIBULATIONS

"CAR-T CELLS AT 15 YEARS: PERSISTENCE OF CD4-ZETA TRANSGENE AND EFFECT ON RESERVOIR" by Naomi E Aronson of Uniformed Services University, Bethesda, MD, USA

THEMED DISCUSSION: ALTERNATIVE DIAGNOSTIC TOOLS FOR UNDERSTANDING NEUROHIV

"SESSION INTRODUCTION" by Avindra Nath of National Institutes of Health, Bethesda, MD, USA

THEMED DISCUSSION: ALTERNATIVE DIAGNOSTIC TOOLS FOR UNDERSTANDING NEUROHIV

"CONSERVED CSF HIV ANTIBODY RESPONSE IN PATIENTS WITH DIVERSE NEUROLOGIC PHENOTYPES" by Isobel Anne Hawes of University of California San Francisco, San Francisco, CA, USA

THEMED DISCUSSION: ALTERNATIVE DIAGNOSTIC TOOLS FOR UNDERSTANDING NEUROHIV

"CNS HIV BEARS ENVELOPE MARKERS CONSISTENT WITH T-CELL ORIGIN IN THE FACE OF ART" by Alex Sigal of Africa Health Research Institute (AHRI), Durban, KwaZulu-Natal, South Africa

THEMED DISCUSSION: ALTERNATIVE DIAGNOSTIC TOOLS FOR UNDERSTANDING NEUROHIV

"RETINAL THINNING CORRELATES WITH BRAIN ATROPHY IN WELL-CONTROLLED HIV INFECTION" by Bryan Smith of National institutes of Health, Bethesda, MD, USA

THEMED DISCUSSION: ALTERNATIVE DIAGNOSTIC TOOLS FOR UNDERSTANDING NEUROHIV

"BIOMARKERS OF NUCLEIC ACID OXIDATION AND NEURODEGENERATION IN CSF IN PWH" by Ronald J. Ellis of University of California, San Diego, CA, USA

THEMED DISCUSSION: ALTERNATIVE DIAGNOSTIC TOOLS FOR UNDERSTANDING NEUROHIV

"PREDICTIVE VALIDATION OF AN UGANDAN INFANT EYE-TRACKING TEST OF MEMORY OF HUMAN FACES" by Michael Joseph Boivin of Michigan State University, East Lansing, MI, USA

THEMED DISCUSSION: ALTERNATIVE DIAGNOSTIC TOOLS FOR UNDERSTANDING NEUROHIV

"MODERATED DISCUSSION" by of

THEMED DISCUSSION: FAT IN FOCUS

"SESSION INTRODUCTION" by Jacqueline Capeau of Sorbonne University, PARIS, France

THEMED DISCUSSION: FAT IN FOCUS

"FAT GAINS OCCUR AFTER ART WITHOUT CHANGES IN METABOLIC RATE OR CALORIC INTAKE" by Allison Ross Eckard of Medical University of South Carolina, Charleston, SC, USA

THEMED DISCUSSION: FAT IN FOCUS

"GREATER WEIGHT GAIN AFTER SWITCH TO INSTI-BASED REGIMEN FROM NNRTI VS PI REGIMENS" by John Koethe of Vanderbilt University Medical Center, Nashville, TN, USA

THEMED DISCUSSION: FAT IN FOCUS

"BODY COMPOSITION CHANGES OVER THE MENOPAUSAL TRANSITION IN HIV+ AND HIV– WOMEN" by Phyllis Tien of UCSF, San Francisco, CA, USA

THEMED DISCUSSION: FAT IN FOCUS

"RESISTIN GENE POLYMORPHISM RELATED TO WEIGHT GAIN AND PSYCHIATRIC SYMPTOMS ON INSTI" by Rumi Minami of National Hospital Organization Kyushu Medical Center, Fukuoka, Japan

THEMED DISCUSSION: FAT IN FOCUS

"ADIPOCYTE DYSFUNCTION DESPITE REDUCED ADIPOSE INFLAMMATION IN DIABETICS WITH HIV" by Samuel Bailin of Vanderbilt University Medical Center, Nashville, TN, USA

THEMED DISCUSSION: FAT IN FOCUS

"CONCLUSION" by Jacqueline Capeau of Sorbonne University, PARIS, France

THEMED DISCUSSION: NOVEL APPROACHES TO STUDY PEDIATRIC ANTIRETROVIRAL DOSING AND SAFETY

"SESSION INTRODUCTION" by Adrie Bekker of Stellenbosch University, Cape Town, South Africa

THEMED DISCUSSION: NOVEL APPROACHES TO STUDY PEDIATRIC ANTIRETROVIRAL DOSING AND SAFETY

"IDENTIFICATION OF AGE-APPROPRIATE DOSING STRATEGIES OF BICTEGRAVIR IN NEONATES" by Fazila Sadik Bunglawala of University of Liverpool, Liverpool, United Kingdom

THEMED DISCUSSION: NOVEL APPROACHES TO STUDY PEDIATRIC ANTIRETROVIRAL DOSING AND SAFETY

"MARAVIROC SAFETY & PHARMACOKINETICS IN HIV-EXPOSED NEONATES" by Julia C Rosebush of The University of Chicago, Chicago, IL, USA

THEMED DISCUSSION: NOVEL APPROACHES TO STUDY PEDIATRIC ANTIRETROVIRAL DOSING AND SAFETY

"ABACAVIR SAFETY AND PHARMACOKINETICS IN NORMAL AND LOW BIRTH WEIGHT INFANTS WITH HIV" by Tim R. Cressey of Harvard T.H. Chan School of Public Health / PHPT-IRD 174, Chiang Mai, Chiang Mai, Thailand

THEMED DISCUSSION: NOVEL APPROACHES TO STUDY PEDIATRIC ANTIRETROVIRAL DOSING AND SAFETY

"ADEQUATE DOLUTEGRAVIR EXPOSURE DOSED BID WITH RIFAMPICIN IN CHILDREN 6 TO <18 YEARS" by Hylke Waalewijn of Radboud University Medical Centre, Amsterdam, Netherlands

THEMED DISCUSSION: NOVEL APPROACHES TO STUDY PEDIATRIC ANTIRETROVIRAL DOSING AND SAFETY

"ABACAVIR SAFETY AND EFFICACY IN YOUNG INFANTS IN SOUTH AFRICAN OBSERVATIONAL COHORTS" by Renee De Waal of University of Cape Town, Cape Town, South Africa

THEMED DISCUSSION: COMING INTO THE LIGHT: HIV IN TRANSGENDER WOMEN AND MEN

"SESSION INTRODUCTION" by Sari L Reisner of Harvard T.H. Chan School of Public Health, Boston, MA, USA

THEMED DISCUSSION: COMING INTO THE LIGHT: HIV IN TRANSGENDER WOMEN AND MEN

"PREEXPOSURE PROPHYLAXIS ADHERENCE AND PERSISTENCE IN KENYAN TRANSGENDER WOMEN AND MSM" by Makobu Kimani of Kenya Medical Research Institute (KEMRI), Kilifi, Kenya

THEMED DISCUSSION: COMING INTO THE LIGHT: HIV IN TRANSGENDER WOMEN AND MEN

"HIV PREVALENCE AND RISK IN MALE‚ TRANSMALE, AND TRANSFEMALE SEX WORKERS IN ZIMBABWE" by Jan Anton Charles Hontelez of Erasmus University Medical Center, Rotterdam, Netherlands

THEMED DISCUSSION: COMING INTO THE LIGHT: HIV IN TRANSGENDER WOMEN AND MEN

"FACTORS ASSOCIATED WITH HIV, HCV, AND HSV-2 SEROSTATUS AMONG US TRANSGENDER WOMEN" by Morgan P Keruly of NIH, Baltimore, MD, USA

THEMED DISCUSSION: COMING INTO THE LIGHT: HIV IN TRANSGENDER WOMEN AND MEN

"HIV PREVALENCE AMONG TRANSGENDER MEN AT AN NYC COMMUNITY HEALTH CENTER" by Asa Radix of Callen-Lorde Community Health Center, New York, NY, USA

THEMED DISCUSSION: COMING INTO THE LIGHT: HIV IN TRANSGENDER WOMEN AND MEN

"PROGRESSION THROUGH THE HIV CARE CONTINUUM FOR TRANSGENDER WOMEN IN THE NA-ACCORD" by Catherine R Lesko of Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA

THEMED DISCUSSION: THE ROAD TO A BETTER VACCINE: CLINICAL TRIALS AND COHORT STUDIES

"SESSION INTRODUCTION" by Richard A. Koup of National Institutes of Health, Bethesda, MD, USA

THEMED DISCUSSION: THE ROAD TO A BETTER VACCINE: CLINICAL TRIALS AND COHORT STUDIES

"THE RV144 VACCINE PRIMED IGG4 AND V1V2-ADCP RESPONSES IN HIV BREAKTHROUGH INFECTIONS" by Thembi Mdluli of US Military HIV Research Program, silver spring, MD, USA

THEMED DISCUSSION: THE ROAD TO A BETTER VACCINE: CLINICAL TRIALS AND COHORT STUDIES

"PHASE I/IIA TRIAL OF HIV CLADE C DNA WITH MF59- OR AS01B-ADJUVANTED CLADE C PROTEIN" by Nigel Garrett of CAPRISA, Durban, South Africa

THEMED DISCUSSION: THE ROAD TO A BETTER VACCINE: CLINICAL TRIALS AND COHORT STUDIES

"MUCOSAL T AND B CELL RESPONSES INDUCED BY ALVAC-HIV/AIDSVAX B/E LATE BOOST STRATEGIES" by Alexandra Schuetz of US Military HIV Research Program (MHRP), Bangkok, Thailand

THEMED DISCUSSION: THE ROAD TO A BETTER VACCINE: CLINICAL TRIALS AND COHORT STUDIES

"ACUTE INFECTION B-CELL DETERMINANTS PREDICT DEVELOPMENT OF NEUTRALIZATION BREADTH" by Shelly J Krebs of Walter Reed Army Institute of Research, Silver Spring, MD, USA

THEMED DISCUSSION: ATTACK OF THE CLONES: CLONAL EXPANSION IN THE HIV RESERVOIR

"SESSION INTRODUCTION" by Linos Vandekerckhove of Ghent University, Ghent, Belgium

THEMED DISCUSSION: ATTACK OF THE CLONES: CLONAL EXPANSION IN THE HIV RESERVOIR

"PARALLEL HIV RNA, INTEGRATION SITE, AND PROVIRAL SEQUENCING IN SINGLE RESERVOIR CELLS" by Kevin Einkauf of Brigham and Women's Hospital, Cambridge, MA, USA

THEMED DISCUSSION: ATTACK OF THE CLONES: CLONAL EXPANSION IN THE HIV RESERVOIR

"SINGLE-CELL ATLAS AND CLONAL EXPANSION DYNAMICS OF CD4+ T CELLS DURING HIV INFECTION" by Jack A Collora of Yale University, New Haven, CT, USA

THEMED DISCUSSION: ATTACK OF THE CLONES: CLONAL EXPANSION IN THE HIV RESERVOIR

"TCR SEQUENCING REVEALS CLONAL EXPANSIONS OF INDUCIBLE RESERVOIRS IN SPECIFIC SUBSETS" by Pierre Gantner of Université de Montréal, MONTREAL, Québec, Canada

THEMED DISCUSSION: ATTACK OF THE CLONES: CLONAL EXPANSION IN THE HIV RESERVOIR

"ONLY A FEW HIV-1 INTEGRATION SITES CONFER GROWTH ADVANTAGE TO INFECTED CELLS IN VIVO" by John M. Coffin of Tufts University, Boston, MA, USA

THEMED DISCUSSION: ATTACK OF THE CLONES: CLONAL EXPANSION IN THE HIV RESERVOIR

"HIV DYNAMICS AND REPOPULATION OF RESERVOIRS IN THE HUMAN BODY" by Antoine Chaillon of University of California San Diego, La Jolla, CA, USA

THEMED DISCUSSION: THE LONG AND THE SHORT OF IT: WHAT'S NEXT FOR LONG-ACTING DRUGS

"SESSION INTRODUCTION" by Ethel D. Weld of The Johns Hopkins University, Baltimore, MD, USA

THEMED DISCUSSION: THE LONG AND THE SHORT OF IT: WHAT'S NEXT FOR LONG-ACTING DRUGS

"CABOTEGRAVIR AND RILPIVIRINE PK FOLLOWING LONG-ACTING HIV TREATMENT DISCONTINUATION" by Susan Ford of GlaxoSmithKline, RTP, NC, USA

THEMED DISCUSSION: THE LONG AND THE SHORT OF IT: WHAT'S NEXT FOR LONG-ACTING DRUGS

"MK-8504 AND MK-8583 (TENOFOVIR PRODRUGS) SINGLE-DOSE PK AND ANTIVIRAL ACTIVITY IN HIV INFECTION" by Randolph P Matthews of Merck Research Laboratories, North Wales, PA, USA

THEMED DISCUSSION: THE LONG AND THE SHORT OF IT: WHAT'S NEXT FOR LONG-ACTING DRUGS

"DOSE-RESPONSE RELATIONSHIP OF SUBCUTANEOUS LONG-ACTING HIV CAPSID INHIBITOR GS-6207" by Eric Daar of Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA, USA

THEMED DISCUSSION: THE LONG AND THE SHORT OF IT: WHAT'S NEXT FOR LONG-ACTING DRUGS

"ANTIRETROVIRAL & RIFAMPICIN COTREATMENT AFFECTS DMPA EXPOSURE: DOSING IMPLICATIONS" by Jose Francis of University of Cape Town, Cape Town, Western Cape, South Africa

THEMED DISCUSSION: NEW DIAGNOSTIC ALGORITHMS FOR TUBERCULOSIS AND OPPORTUNISTIC INFECTIONS

"SESSION INTRODUCTION" by Andrew D Kerkhoff of University of California, San Francisco, San Francisco, CA, USA

THEMED DISCUSSION: NEW DIAGNOSTIC ALGORITHMS FOR TUBERCULOSIS AND OPPORTUNISTIC INFECTIONS

"PREVALENCE OF TB SYMPTOMS, DIAGNOSIS, AND TREATMENT AMONG HIV PATIENTS NOT ON ART" by Alana T Brennan of Boston University School of Public Health, Boston, MA, USA

THEMED DISCUSSION: NEW DIAGNOSTIC ALGORITHMS FOR TUBERCULOSIS AND OPPORTUNISTIC INFECTIONS

"CHARACTERISATION OF SOUTH AFRICA’S XPERT MTB/RIF ULTRA 'TRACE' LABORATORY RESULTS" by Lesley Scott of University of the Witwatersrand, Johannesburg, Gauteng, South Africa

THEMED DISCUSSION: NEW DIAGNOSTIC ALGORITHMS FOR TUBERCULOSIS AND OPPORTUNISTIC INFECTIONS

"PROMISING COMBINED IMMUNOLOGICAL ASSAYS TO DIAGNOSE CHILDHOOD TUBERCULOSIS" by Jean-Pierre Molès of Inserm, Montpellier, France

THEMED DISCUSSION: NEW DIAGNOSTIC ALGORITHMS FOR TUBERCULOSIS AND OPPORTUNISTIC INFECTIONS

"DIAGNOSTIC PERFORMANCE OF A SEMIQUANTITATIVE POINT-OF-CARE ASSAY FOR CRYPTOCOCCOSIS" by Tadeo Kandole Kiiza of Makerere University, Kampala, kampala, Uganda

THEMED DISCUSSION: NEW DIAGNOSTIC ALGORITHMS FOR TUBERCULOSIS AND OPPORTUNISTIC INFECTIONS

"SUPERIOR ACCURACY OF THE MP1P ANTIGEN ASSAY OVER CULTURES IN DIAGNOSING TALAROMYCOSIS" by Ly Trieu Vo of Ho Chi Minh City Medicine and Pharmacy University, Ho Chi Minh City, Viet Nam

THEMED DISCUSSION: MAKING SENSE OF IT ALL: HIV SUSCEPTIBILITY IN THE FEMALE GENITAL TRACT

"SESSION INTRODUCTION" by Caroline Mitchell of Harvard Medical School/Massachusetts General Hospital, Boston, MA, USA

THEMED DISCUSSION: MAKING SENSE OF IT ALL: HIV SUSCEPTIBILITY IN THE FEMALE GENITAL TRACT

"GENITAL SECRETIONS FROM WOMEN WITH BACTERIAL VAGINOSIS ENHANCE HIV INFECTION EX VIVO" by Marla J Keller of Albert Einstein College of Medicine, Bronx, NY, USA

THEMED DISCUSSION: MAKING SENSE OF IT ALL: HIV SUSCEPTIBILITY IN THE FEMALE GENITAL TRACT

"DMPA-IM DRIVES CERVICAL TH17 HIV TARGET-CELL ACCUMULATION IN WOMEN IN ECHO TRIAL" by Rubina Bunjun of University of Cape Town, Cape Town, South Africa

THEMED DISCUSSION: MAKING SENSE OF IT ALL: HIV SUSCEPTIBILITY IN THE FEMALE GENITAL TRACT

"INCREASED GENITAL INFLAMMATION IN WOMEN RANDOMIZED TO COPPER IUD IN THE ECHO TRIAL" by Tanko F Ramla of University of Cape Town, Cape Town, South Africa

THEMED DISCUSSION: MAKING SENSE OF IT ALL: HIV SUSCEPTIBILITY IN THE FEMALE GENITAL TRACT

"A COMBINED ESTROGEN/PROGESTIN VAGINAL RING IMPROVES VAGINAL MICROBIAL COMMUNITIES" by Nicole H. Tobin of University of California, Los Angeles, Los Angeles, CA, USA